Re: Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study

Affiliations

¹ Sorbonne University, GRC 5, Predictive Onco-Urology, AP-HP, Pitié-Salpêtrière Hôpital, Paris, France; Division of Urology, Geneva University Hospitals, Geneva, Switzerland.
² Sorbonne University, GRC 5, Predictive Onco-Urology, AP-HP, Pitié-Salpêtrière Hôpital, Paris, France.
³ Sorbonne University, GRC 5, Predictive Onco-Urology, AP-HP, Pitié-Salpêtrière Hôpital, Paris, France. Electronic address: morgan.roupret@aphp.fr.

Comment

Elisabeth Grobet-Jeandin et al. Eur Urol. 2022 Apr.

. 2022 Apr;81(4):430.

doi: 10.1016/j.eururo.2022.01.011. Epub 2022 Jan 31.

¹ Sorbonne University, GRC 5, Predictive Onco-Urology, AP-HP, Pitié-Salpêtrière Hôpital, Paris, France; Division of Urology, Geneva University Hospitals, Geneva, Switzerland.
² Sorbonne University, GRC 5, Predictive Onco-Urology, AP-HP, Pitié-Salpêtrière Hôpital, Paris, France.
³ Sorbonne University, GRC 5, Predictive Onco-Urology, AP-HP, Pitié-Salpêtrière Hôpital, Paris, France. Electronic address: morgan.roupret@aphp.fr.

No abstract available

Comment on

Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study.
Catto JWF, Gordon K, Collinson M, Poad H, Twiddy M, Johnson M, Jain S, Chahal R, Simms M, Dooldeniya M, Bell R, Koenig P, Conroy S, Goodwin L, Noon AP, Croft J, Brown JM; BRAVO study group. Catto JWF, et al. J Clin Oncol. 2021 Jan 20;39(3):202-214. doi: 10.1200/JCO.20.01665. Epub 2020 Dec 17. J Clin Oncol. 2021. PMID: 33332191 Free PMC article. Clinical Trial.